190 related articles for article (PubMed ID: 32566650)
41. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
42. Insights regarding novel biomarkers and the pathogenesis of primary colorectal carcinoma based on bioinformatic analysis.
Wang YR; Meng LB; Su F; Qiu Y; Shi JH; Xu X; Luo QF
Comput Biol Chem; 2020 Apr; 85():107229. PubMed ID: 32058945
[TBL] [Abstract][Full Text] [Related]
43. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
44. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
Shen Y; Dong S; Liu J; Zhang L; Zhang J; Zhou H; Dong W
Biomed Res Int; 2020; 2020():9710421. PubMed ID: 32337286
[TBL] [Abstract][Full Text] [Related]
45. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
Xiong Y; You W; Wang R; Peng L; Fu Z
Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625
[TBL] [Abstract][Full Text] [Related]
46. Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
Hammad A; Zheng ZH; Namani A; Elshaer M; Wang XJ; Tang X
BMC Cancer; 2021 May; 21(1):607. PubMed ID: 34034704
[TBL] [Abstract][Full Text] [Related]
47. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
48. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
49. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
Chen J; Wang Z; Shen X; Cui X; Guo Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
[TBL] [Abstract][Full Text] [Related]
50. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.
Zhang X; Yin S; Ma K
J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431
[TBL] [Abstract][Full Text] [Related]
51. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
52. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
53. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
54. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
Sun LC; Qian HX
Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
[TBL] [Abstract][Full Text] [Related]
55. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
56. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
57. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages.
Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W
Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889
[TBL] [Abstract][Full Text] [Related]
58. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
Zhang X; Yang L; Chen W; Kong M
Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
[TBL] [Abstract][Full Text] [Related]
59. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
60. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]